» Articles » PMID: 9757178

Prostate Cancer: 1. The Descriptive Epidemiology in Canada

Overview
Journal CMAJ
Date 1998 Oct 3
PMID 9757178
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A 70-year-old woman who experienced a long period of depression after her first husband's death from prostate cancer at the age of 63 has become increasingly anxious about her own health and that of her close family. A few years ago she married a man her own age; he is in good physical condition. Last year the family spent much of the winter in Florida, where the woman noticed several studies in the media suggesting that an epidemic of prostate cancer is occurring in North America and that because early detection can save lives men of retirement age should be checked by their physicians as soon as possible. In addition, 2 close friends recently diagnosed with prostate cancer. On his latest fishing trip her husband learned from a friend that 1 in 8 men get prostate cancer. He has not seen his family physician for several years, but his wife has booked an appointment for them to discuss their concerns.

Citing Articles

Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model.

Xu X, Chen X, Hu H, Dailey A, Taylor B BMC Cancer. 2015; 15:806.

PMID: 26502956 PMC: 4623905. DOI: 10.1186/s12885-015-1833-5.


Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.

Beydoun H, Shroff M, Mohan R, Beydoun M Cancer Causes Control. 2011; 22(11):1483-95.

PMID: 21800039 PMC: 3443554. DOI: 10.1007/s10552-011-9822-8.


The changing age distribution of prostate cancer in Canada.

Neutel C, Gao R, Blood P, Gaudette L Can J Public Health. 2007; 98(1):60-4.

PMID: 17278680 PMC: 6976190.


Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000.

Neutel C, Gao R, Blood P, Gaudette L Can J Public Health. 2006; 97(3):177-82.

PMID: 16827401 PMC: 6975692.


Prostate cancer incidence and mortality rates and trends in the United States and Canada.

McDavid K, Lee J, Fulton J, Tonita J, Thompson T Public Health Rep. 2004; 119(2):174-86.

PMID: 15192905 PMC: 1497609. DOI: 10.1177/003335490411900211.


References
1.
Gray R, Klotz L, Iscoe N, Fitch M, Franssen E, Johnson B . Results of a survey of Canadian men with prostate cancer. Can J Urol. 1997; 4(2):359-365. View

2.
Lu-Yao G, Greenberg E . Changes in prostate cancer incidence and treatment in USA. Lancet. 1994; 343(8892):251-4. DOI: 10.1016/s0140-6736(94)91109-6. View

3.
Morrison H, Macneill I, Miller D, Levy I, Xie L, Mao Y . The impending Canadian prostate cancer epidemic. Can J Public Health. 1995; 86(4):274-8. View

4.
Levy I, Gibbons L, Collins J, PERKINS D, Mao Y . Prostate cancer trends in Canada: rising incidence or increased detection?. CMAJ. 1993; 149(5):617-24. PMC: 1486022. View

5.
Mercer S, Goel V, Levy I, Ashbury F, Iverson D, Iscoe N . Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions. Can J Public Health. 1997; 88(5):327-32. PMC: 6990359. View